Objectives: Time testing is essential with any valvular procedure, esp
ecially when a new concept is introduced such as the mitral stentless
valve. Our purpose is to evaluate the results obtained over 4 years wi
th this operation, particularly to attest the impact of preservation o
f annulo ventricular continuity on the long term results of these pati
ents. Methods: From March 1992 to August 1996, 120 patients had their
mitral valves replaced with a porcine stentless mitral valve. The obse
rvation period was 54 months with total patients follow-up of 3424 mon
ths with a mean of 28.5 months. The age ranged from 11 to 72 years (me
an 35.22 +/- 14.98). There were 73 females (60.8%) and 47 males (39.2%
). The predominant etiology was rheumatic heart disease. Associated pr
ocedures were performed In 12 patients (10%), and the great majority o
f the patients were in functional class III and IV (NYHA). Results: Ho
spital mortality occurred in seven patients (5.83%) non valve related
except for one early case of endocarditis. Early reoperation related t
o technical failure were necessary in 4 patients without mortality. Fo
llow-up was accomplished in 101 patients and ranged from 2 to 54 month
s, Late reoperations were required in 16 patients (nine due to mitral
insufficiency, five because of endocarditis and two for mitral stenosi
s), Most reoperations were related to technical failure. Among the 82
patients presently in control, 72 showed a competent mitral stentless
valve, eight with stable mild mitral regurgitation and in two a decrea
sed mitral orifice. Hemodynamic performance of the valve has been exce
llent in this group, particularly in patients with left ventricular dy
sfunction. Conclusion: Although technical complexity remains the main
cause of reoperations with this valve, experience has shown that it no
t only provides preservation of the left ventricular function hut also
promised significant increase of the ejection fraction in patients wi
th poor left ventricular function. (C) 1997 Elsevier Science B.V.